First Time Loading...
J

Japan Medical Dynamic Marketing Inc
TSE:7600

Watchlist Manager
Japan Medical Dynamic Marketing Inc
TSE:7600
Watchlist
Price: 670 JPY 1.82% Market Closed
Updated: Apr 19, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Japan Medical Dynamic Marketing Inc

Wall Street analysts forecast Japan Medical Dynamic Marketing Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Japan Medical Dynamic Marketing Inc is 2 380 JPY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
2 380 JPY
255% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
2 380 JPY
255% Upside
Highest
Price Target
Not Available
Japan Medical Dynamic Marketing Inc Competitors:
Price Targets
A
2784
Alfresa Holdings Corp
2% Upside
GALE
Galenica AG
12% Upside
EBO
EBOS Group Ltd
17% Upside
9729
Tokai Corp (Gifu)
11% Upside
A
2784
Alfresa Holdings Corp
2% Upside
GALE
Galenica AG
12% Upside
EBO
EBOS Group Ltd
17% Upside
9729
Tokai Corp (Gifu)
11% Upside
CAU
Cronos Australia Ltd
178% Upside
1345
China Pioneer Pharma Holdings Ltd
80% Upside
PGC
Paragon Care Ltd
3% Downside
FAGR
Fagron NV
21% Upside

Revenue
Forecast

Revenue Estimate
Japan Medical Dynamic Marketing Inc

For the last 8 years the compound annual growth rate for Japan Medical Dynamic Marketing Inc's revenue is 8%. The projected CAGR for the next 3 years is 12%.

8%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Japan Medical Dynamic Marketing Inc

Operating Income forecast
is not available for
Japan Medical Dynamic Marketing Inc

Net Income
Forecast

Net Income Estimate
Japan Medical Dynamic Marketing Inc

The compound annual growth rate of Japan Medical Dynamic Marketing Inc's net income for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Japan Medical Dynamic Marketing Inc's stock price target?
Price Target
2 380 JPY

According to Wall Street analysts, the average 1-year price target for Japan Medical Dynamic Marketing Inc is 2 380 JPY .

What is Japan Medical Dynamic Marketing Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Japan Medical Dynamic Marketing Inc's revenue is 8%. The projected CAGR for the next 3 years is 12%.

What is Japan Medical Dynamic Marketing Inc's Net Income forecast?
Projected CAGR
17%

The compound annual growth rate of Japan Medical Dynamic Marketing Inc's net income for the next 3 years is 17%.

ALPHA SPREAD
Join more than 129,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.